Inhibition of [3H]nitrendipine binding by phospholipase A2.
Phospholipase A2 from several sources inhibited [3H]nitrendipine binding to membranes from brain, heart and ileal longitudinal muscle. The enzymes from bee venom and Russell's viper venom were most potent, having IC50 values of approximately 5 and 14 ng/ml, respectively, in all three membrane preparations. Inhibition of binding by bee venom phospholipase A2 was time- and dose-dependent. Mastoparan, a known facilitator of phospholipase A2 enzymatic activity, shifted the bee venom phospholipase A2 dose-response curve to the left. Pretreatment of brain membranes with bee venom phospholipase A2 (10 ng/ml) for 15 min caused a 2-fold increase in the Kd without changing the Bmax compared with untreated membranes. Extension of the preincubation period to 30 min caused no further increase in the Kd but significantly decreased the Bmax to 71% the value for untreated membranes. [3H]Nitrendipine, preincubated with bee venom phospholipase A2, was recovered and found to be fully active, indicating that the phospholipase A2 did not modify the ligand. It is concluded that phospholipase A2 acts on the membrane at or near the [3H]nitrendipine binding site and that phospholipids play a key role in the interactions of 1,4 dihydropyridine calcium channel antagonists with the dihydropyridine binding site.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001514:Bee Venoms; D001665:Binding Sites; D001921:Brain / Q000378:metabolism*; D015220:Calcium Channels; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006168:Guinea Pigs; D007082:Ileum / Q000378:metabolism*; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000378:metabolism; D009568:Nitrendipine; D010455:Peptides; D010740:Phospholipases / Q000494:pharmacology*; D010741:Phospholipases A / Q000494:pharmacology*; D054467:Phospholipases A2; D051381:Rats; D011919:Rats, Inbred Strains; D011978:Receptors, Nicotinic / Q000378:metabolism*; D012910:Snake Venoms; D013997:Time Factors; D014757:Viper Venoms; D014862:Wasp Venoms / Q000494:pharmacology
D001095:Arachidonic Acids; D001514:Bee Venoms; D015220:Calcium Channels; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; D011978:Receptors, Nicotinic; D012910:Snake Venoms; D014757:Viper Venoms; D014862:Wasp Venoms; D016718:Arachidonic Acid; C037500:mastoparan; D009568:Nitrendipine; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; D009543:Nifedipine